← Back to Patent Explorer
US4704356A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of diagnosing cartilage tissue abnormalities

Assignee: RUSH-PESBYTERIAN-ST LUKE'S
•
Filing: 1984-03-27
•
Granted: 1987-11-03
•
Expires: 2004-03-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract It is found that abnormal levels of keratan sulfate in the peripheral blood are indicative of abnormalities of cartilage or cartilage-like tissues. Specifically, elevated levels of keratan sulfate in the peripheral blood plasma or serum are indicative of osteoarthritis and either substantially complete absence of or very elevated levels of keratan sulfate in the peripheral blood are indicative of muscular dystrophy and related disorders. The level of keratan sulfate in the peripheral blood is determined by an immunoassay using a monoclonal antibody. Preferably the immunoassay employs a colorimetric reporter system.

Inventors

  • 👤 Eugene J. Thonar

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 15:13
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/6887; G01N2800/00; G01N2800/10; G01N2800/105; Y; Y10; Y10S; Y10S436/00; Y10S436/811; Y10S436/815

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 62 words
A method for indicating an abnormality of cartilage, disc or corneal tissue in a mammal, which method comprises measuring, by an immunoassay of a specimen of the peripheral blood serum or plasma of the mammal employing a monoclonal antibody reactive with keratan sulfate, the level of keratan sulfate in said specimen and noting an abnormal level of keratan sulfate in said specimen.
Claim 2
Independent Claim 62 words
A method for indicating an abnormality of cartilage, disc or corneal tissue in a mammal, which method comprises measuring, by an immunoassay of a specimen of the peripheral blood serum or plasma of the mammal employing a monoclonal antibody reactive with keratan sulfate, the level of keratan sulfate in said specimen and noting an abnormal level of keratan sulfate in said specimen.
Claim 3
Dependent Claim 11 words
A method according to claim 1 wherein the mammal is human.
Claim 4
Dependent Claim 30 words
A method according to claim 2 wherein the abnormality to be indicated is osteoarthritis and the level of keratan sulfate in the specimen of serum or plasma is abnormally high.
Claim 5
Dependent Claim 32 words
A method according to claim 2 wherein the abnormality to be indicated is mascular corneal dystrophy and the level of keratan sulfate in the specimen of serum or plasma is abnormally low.
Claim 6
Dependent Claim 14 words
A method according to claim 3 wherein the immunoassay is an enzyme-linked immunosorbent assay.
Claim 7
Dependent Claim 14 words
A method according to claim 4 wherein the immunoassay is an enzyme-linked immunosorbent assay.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-11-02 1991-05-04 1991-11-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-11-02 1995-05-04 1995-11-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-11-02 1999-05-04 1999-11-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag